UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nivolumab + ipilimumab versus platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer: Three-year update from CheckMate 227 Part 1

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9500-9500

2020

Volltextzugriff (PDF)

Nivolumab (NIVO) + ipilimumab (IPI) + 2 cycles of platinum-doublet chemotherapy (chemo) vs 4 cycles chemo as first-line (1L) treatment (tx) for stage IV/recurrent non-small cell lung cancer (NSCLC): CheckMate 9LA

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.9501-9501

2020

Volltextzugriff (PDF)

Editorial - Quid novi ex Nubia

Études et Travaux, 2019-12 (32), p.7

Żurawski, Bogdan

2019

Volltextzugriff (PDF)

“Oh, My Beloved, Great Bull!” An Interdisciplinary Approach to Cattle as a Marker of Economic and Political Status in Medieval Sub-Saharan Societies

Journal of African archaeology, 2023-06, Vol.21 (1), p.46-62

2023

Volltextzugriff (PDF)

Living with the Past in Modern Sudanese Village. Traditional Pottery Production in the Ad-Dabba Bend of the Nile

Études et Travaux, 2019-12 (32), p.23

2019

Volltextzugriff (PDF)

Banganarti and Selib in 2011/2012 and 2013

Polish archaeology in the Mediterranean, 2016-02, Vol.XXIV (1), p.369-388

Żurawski, Bogdan

2016

Volltextzugriff (PDF)

DESTINY-Breast07: Dose-expansion interim analysis of T-DXd monotherapy and T-DXd + pertuzumab in patients with previously untreated HER2+ mBC

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.1009-1009

2024

Volltextzugriff (PDF)

Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial

European journal of cancer (1990), 2024-11, Vol.211, p.114296, Article 114296

2024

Volltextzugriff (PDF)

Cost-effectiveness analysis of treatment of patients with colorectal cancer with FOLFOX4 and XELOX regimens

Nowotwory, 2017-06, Vol.66 (6), p.470-476

2017

Volltextzugriff (PDF)

CONTACT-02: Phase 3 study of cabozantinib (C) plus atezolizumab (A) vs second novel hormonal therapy (NHT) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.18-18

2024

Volltextzugriff (PDF)

Subcutaneous nivolumab (NIVO SC) vs intravenous nivolumab (NIVO IV) in patients with previously treated advanced or metastatic clear cell renal cell carcinoma (ccRCC): Pharmacokinetics (PK), efficacy, and safety results from CheckMate 67T

Journal of clinical oncology, 2024-02, Vol.42 (4_suppl), p.LBA360-LBA360

2024

Volltextzugriff (PDF)

Whole BRCA1/2 exome screening in breast cancer tissue: Preliminary study on 45 patients negative in preventive screening analysis in Poland which cover the most common mutations in BRCA1/2 tested in blood

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e13615-e13615

2018

Volltextzugriff (PDF)

Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): results from a double-blind, randomised, phase 3 trial

The Lancet (British edition), 2023-02, Vol.401 (10379), p.821-832

2023

Volltextzugriff (PDF)

Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study

Journal of clinical oncology, 2024-06

2024

Volltextzugriff (PDF)

First-line nivolumab (NIVO) plus ipilimumab (IPI) plus two cycles of chemotherapy (chemo) versus chemo alone (4 cycles) in patients with advanced non-small cell lung cancer (NSCLC): Two-year update from CheckMate 9LA

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.9000-9000

2021

Volltextzugriff (PDF)

Banganarti and Selib in the 2013/2014 and 2014/2015 seasons with Appendix 1: Pottery from Selib. Preliminary report (2013/2014 and 2014/2015 seasons), Appendix 2: Osteoarchaeological analyses of skeletal material from Selib 1 and Banganarti (2013/2014 and 2014/2015 seasons)

Polish archaeology in the Mediterranean, 2017-05, Vol.25, p.349-402

2017

Volltextzugriff (PDF)

Mutation analysis in colorectal adenocarcinoma specimens to targeted treatment

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e14639-e14639

2014

Volltextzugriff (PDF)

Efficacy and safety of CetuGEX in recurrent/metastatic squamous cell carcinoma of the head and neck (RM-HNSCC): Results from the randomized phase II RESGEX study

Journal of clinical oncology, 2018-02, Vol.36 (5_suppl), p.59-59

2018

Volltextzugriff (PDF)

Handbook of Ancient Nubia

Raue, Dietrich

1st edition., 2019

Volltextzugriff (PDF)

EN1-4. First-line nivolumab + ipilimumab + 2 cycles chemotherapy in advanced NSCLC : CheckMate 9LA 2-y data

Japanese Journal of Lung Cancer, 2021-10, Vol.61 (6), p.547-547

2021

Volltextzugriff (PDF)

SHEMKHIYA: SEASON 2006 : Fourth cataract (MSDAP)

Polish archaeology in the Mediterranean, 2006, Vol.18, p.433-444

ZURAWSKI, Bogdan

2006

Volltextzugriff (PDF)

BANGANARTI: THE 2006 SEASON : BANGANARTI

Polish archaeology in the Mediterranean, 2006, Vol.18, p.385-395

ZURAWSKI, Bogdan

2006

Volltextzugriff (PDF)

BANGANARTI AND SELIB: TWO FIELD SEASONS IN 2008 : SUDAN

Polish archaeology in the Mediterranean, 2008, Vol.20, p.251-266

ZURAWSKI, Bogdan T

2008

Volltextzugriff (PDF)

Banganarti : 2004 season including activities at the fortress of ed-Deiga

Polish archaeology in the Mediterranean, 2004, Vol.16, p.297-308

ZURAWSKI, Bogdan

2004

Volltextzugriff (PDF)

1 – 25 von 53

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(45)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Art And Archaeology
(15)
Ancient Civilizations Of The Near East
(14)
Sudan
(14)
Archaeology
(13)
Banganarti
(3)
Nubia
(3)
Selib
(3)
Ancient World
(2)
Cancer
(2)
Excavations, Topography And Recording
(2)
Field Technics
(2)
Generalities
(2)
Meroitic Settlement
(2)
Methods
(2)
Research Principies
(2)
Adaptation, Psychological
(1)
Adult
(1)
Africa--Nubia
(1)
African Ceramics
(1)
Aged
(1)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Polish Archaeology In The Mediterranean
(31)
Journal Of Clinical Oncology
(11)
Nowotwory
(2)
Études Et Travaux
(2)
European Journal Of Cancer
(1)
Japanese Journal Of Lung Cancer
(1)
Journal Of African Archaeology
(1)
Psychiatria Polska
(1)
The Lancet
(1)

4 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Nivolumab + ipilimumab versus platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer: Three-year update from CheckMate 227 Part 1

Nivolumab (NIVO) + ipilimumab (IPI) + 2 cycles of platinum-doublet chemotherapy (chemo) vs 4 cycles chemo as first-line (1L) treatment (tx) for stage IV/recurrent non-small cell lung cancer (NSCLC): CheckMate 9LA

Editorial - Quid novi ex Nubia

“Oh, My Beloved, Great Bull!” An Interdisciplinary Approach to Cattle as a Marker of Economic and Political Status in Medieval Sub-Saharan Societies

Living with the Past in Modern Sudanese Village. Traditional Pottery Production in the Ad-Dabba Bend of the Nile

Banganarti and Selib in 2011/2012 and 2013

DESTINY-Breast07: Dose-expansion interim analysis of T-DXd monotherapy and T-DXd + pertuzumab in patients with previously untreated HER2+ mBC

Five-year outcomes with first-line nivolumab plus ipilimumab with 2 cycles of chemotherapy versus 4 cycles of chemotherapy alone in patients with metastatic non-small cell lung cancer in the randomized CheckMate 9LA trial

Cost-effectiveness analysis of treatment of patients with colorectal cancer with FOLFOX4 and XELOX regimens

CONTACT-02: Phase 3 study of cabozantinib (C) plus atezolizumab (A) vs second novel hormonal therapy (NHT) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)

Subcutaneous nivolumab (NIVO SC) vs intravenous nivolumab (NIVO IV) in patients with previously treated advanced or metastatic clear cell renal cell carcinoma (ccRCC): Pharmacokinetics (PK), efficacy, and safety results from CheckMate 67T

Whole BRCA1/2 exome screening in breast cancer tissue: Preliminary study on 45 patients negative in preventive screening analysis in Poland which cover the most common mutations in BRCA1/2 tested in blood

Adjuvant nivolumab plus ipilimumab versus placebo for localised renal cell carcinoma after nephrectomy (CheckMate 914): results from a double-blind, randomised, phase 3 trial

Phase 3 MAGNITUDE study: First results of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) as first-line therapy in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) with and without homologous recombination repair (HRR) gene alterations

Subcutaneous Versus Intravenous Amivantamab, Both in Combination With Lazertinib, in Refractory Epidermal Growth Factor Receptor–Mutated Non–Small Cell Lung Cancer: Primary Results From the Phase III PALOMA-3 Study

First-line nivolumab (NIVO) plus ipilimumab (IPI) plus two cycles of chemotherapy (chemo) versus chemo alone (4 cycles) in patients with advanced non-small cell lung cancer (NSCLC): Two-year update from CheckMate 9LA

Banganarti and Selib in the 2013/2014 and 2014/2015 seasons with Appendix 1: Pottery from Selib. Preliminary report (2013/2014 and 2014/2015 seasons), Appendix 2: Osteoarchaeological analyses of skeletal material from Selib 1 and Banganarti (2013/2014 and 2014/2015 seasons)

Mutation analysis in colorectal adenocarcinoma specimens to targeted treatment

Efficacy and safety of CetuGEX in recurrent/metastatic squamous cell carcinoma of the head and neck (RM-HNSCC): Results from the randomized phase II RESGEX study

Handbook of Ancient Nubia

EN1-4. First-line nivolumab + ipilimumab + 2 cycles chemotherapy in advanced NSCLC : CheckMate 9LA 2-y data

SHEMKHIYA: SEASON 2006 : Fourth cataract (MSDAP)

BANGANARTI: THE 2006 SEASON : BANGANARTI

BANGANARTI AND SELIB: TWO FIELD SEASONS IN 2008 : SUDAN

Banganarti : 2004 season including activities at the fortress of ed-Deiga

Aktive Filter

Suchergebnisse filtern